Patents by Inventor Francis Martin

Francis Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170033353
    Abstract: Silicon-silica hybrid materials made by metallothermal reduction from silica and methods of producing such compositions are provided. The compositions have novel properties and provide significant improvements in Coulombic efficiency, dilithiation capacity, and cycle life when used as anode materials in lithium battery cells.
    Type: Application
    Filed: April 9, 2015
    Publication date: February 2, 2017
    Inventors: Francis Martin Behan, Indrajit Dutta, Brian Alan Kent, Shawn Michael O'Malley, Vitor Marino Schneider, Randall Eugene Youngman
  • Patent number: 8999993
    Abstract: The invention relates to novel compounds, processes for their preparation and their use in protecting biological materials from radiation damage (radioprotection).
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: April 7, 2015
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Roger Francis Martin, Jonathan White, Pavel Lobachevsky, David Winkler, Colin Skene, Sebastian Marcuccio
  • Publication number: 20140324158
    Abstract: A biosorbable magnetisable endoprosthesis, may be useful in the therapy of restenosis. A method for the treatment of prevention of restenosis or a disease of thecoronary artery, comprises fitting a patent with an endoprosthesis according to the invention, which has either been magnetized prior to placement in the body or which is magnetized in situ, and administering to the patient magnetized cells capable of repairing an artery.
    Type: Application
    Filed: October 1, 2012
    Publication date: October 30, 2014
    Applicant: MAGNUS STENT IC
    Inventors: John Francis Martin, Anthony Mathur
  • Patent number: 8796277
    Abstract: The invention relates to radioprotectors of formula (I), processes for their preparation and their use in protecting biological materials from radiation damage. In diagnostic and therapeutic radiology, particularly in cancer radiotherapy, the radioprotectors of the present invention may be used to protect certain normal tissues or structures from radiation damage. The radioprotectors of formula (I) may also have uses in decreasing the effects of irradiation in non-medical scenarios, both civil and military.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: August 5, 2014
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Roger Francis Martin, Jonathan Michael White
  • Publication number: 20140121160
    Abstract: An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF against may be a VEGF peptide or a gene construct encoding or expressing such a PI-peptide.
    Type: Application
    Filed: October 29, 2012
    Publication date: May 1, 2014
    Inventors: John Francis MARTIN, Charles Henry RODECK
  • Publication number: 20140045907
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 13, 2014
    Applicant: FinVector Vision Therapies Ltd
    Inventors: Hugh Edward MONTGOMERY, John Francis Martin, Jorge Daniel Erusalimsky
  • Patent number: 8604070
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: December 10, 2013
    Assignee: FinVector Vision Therapies, Ltd.
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Publication number: 20130224741
    Abstract: The invention concerns a method for determining the Tuber species and fertility of a truffle sample, said method comprising: - identifying whether said truffle sample comprises a first nucleotide sequence associated with a first mating type idiomorph (MAT1-2); and - identifying whether said truffle sample comprises a second nucleotide sequence associated with a second mating type idiomorph (MAT1-1); the fertility of said truffle sample requiring the presence of both the first and the second nucleotide sequences.
    Type: Application
    Filed: September 7, 2011
    Publication date: August 29, 2013
    Inventors: Francis Martin, Claude Murat-Furminieux, Francesco Paolocci, Andrea Rubini, Claudia Riccioni, Beatrice Belfiori, Sergio Arcioni
  • Publication number: 20130109678
    Abstract: The invention relates to novel compounds, processes for their preparation and their use in protecting biological materials from radiation damage (radioprotection).
    Type: Application
    Filed: April 6, 2011
    Publication date: May 2, 2013
    Applicant: PETER MACCALLUM CANCER INSTITUTE
    Inventors: Roger Francis Martin, Jonathan White, Pavel Lobachevsky, David Winkler, Colin Skene, Sebastian Maruccio
  • Publication number: 20130097014
    Abstract: Two digital files are combined through an automatic process to create a third digital combination file. A media file is uploaded to a media file database and an advertising file is uploaded to an advertising database. A first advertising file is selected to be combined with a second media file using smart logic and analysis. The selected first advertising file and second media file are automatically combined to create a third, new, unitary combination file. The third new combination file is then made available to consumers/end users through download or streaming without charge. The artists who provide the media files may be compensated according to the number of times each of their songs/media are downloaded or streamed by a consumer/end user.
    Type: Application
    Filed: April 3, 2012
    Publication date: April 18, 2013
    Applicant: AUXILIARY BAY , LLC
    Inventors: John Francis Martin, Chaitanya Dalvi
  • Patent number: 8334271
    Abstract: An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF agonist may be a VEGF peptide or a gene construct encoding or expressing such a peptide.
    Type: Grant
    Filed: February 22, 2008
    Date of Patent: December 18, 2012
    Assignee: Ark Therapeutics, Ltd.
    Inventors: John Francis Martin, Charles Henry Rodeck
  • Publication number: 20120308522
    Abstract: Vascular endothelial growth factor (VEGF) has utility in the treatment of intimal hyperplasia, hypertension and atherosclerosis, and of conditions susceptible to treatment with agents that produce nitric oxide or prostacyclin. Instead of VEGF, an equivalent agent such as an agonist of VEGF receptors may be given, as may nucleic acid encoding such an agonist. The agent may successfully be administered via the adventitial surface of a blood vessel, e.g. using a device which defines a reservoir between the body wall and the vessel's adventitial surface, the reservoir being at least part-filled by a pharmaceutical formulation containing the agent to be delivered.
    Type: Application
    Filed: June 27, 2012
    Publication date: December 6, 2012
    Inventors: John Francis MARTIN, Seppo Yla-Herttuala, Stephen George Edward Barker
  • Publication number: 20120178784
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Application
    Filed: January 30, 2012
    Publication date: July 12, 2012
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Patent number: 8211387
    Abstract: A combustor for oxidizing a combustion fuel and pre-heating one or more reactants for fuel reforming. The combustor includes an elongated housing having an inlet for receiving a combustion fuel and an outlet for exhausting combustion products. The elongated housing further includes a cylindrical side wall, a bottom wall, and a top wall. Inert particles are disposed within the housing adjacent the inlet. A combustion catalyst bed is disposed within the housing above the inert particles that is a mixture of inert particles and combustion catalyst. The inert particles and the combustion catalyst preferably have a volumetric ratio of inert particles to catalyst between about 2:1 and about 4:1. The combustor has at least one heat exchanger within the combustion catalyst bed for heating a reformer reactant and generating steam. Preferably, the combustor includes at least two heat exchangers within the combustion catalyst bed, the heat exchanging elements have different surface areas.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: July 3, 2012
    Assignee: Texaco Inc.
    Inventors: Vijay Anant Deshpande, Curtis L. Krause, Paul Francis Martin, Kevin Hoa Nguyen, James F. Stevens, William Spencer Wheat
  • Patent number: 8097238
    Abstract: The present invention relates to cell targeting conjugates and in particular, but not exclusively, to methods of their use in selectively eliminating and in selectively imaging target cells. The invention also relates to processes for production of the conjugates and to intermediate compounds that may be used in production of a specific class of cell targeting conjugates. In one embodiment there is provided a cell targeting conjugate comprising the following components that are covalently conjugated via a linker that is degradable within the target cells: i) a DNA minor groove binding ligand incorporating an effective Auger electron-emitting and/or gamma-emitting and/or positron-emitting atom or photoactive moiety; ii) a target cell specific protein or peptide that is capable of internalization by target cells.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: January 17, 2012
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Roger Francis Martin, Jonathan Michael White, Pavel Nikolaevich Lobachevsky, Thomas Chris Karagiannis
  • Patent number: 8061338
    Abstract: A retaining apparatus is provided for mating an ignition coil to a spark plug.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: November 22, 2011
    Assignee: Ford Global Technologies, LLC
    Inventors: Jim Gibboney, Francis Martin Donahue
  • Patent number: 8003679
    Abstract: Inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia, such as stroke.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: August 23, 2011
    Assignee: ArkTherapeutics Group, plc
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Patent number: 7998953
    Abstract: It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: August 16, 2011
    Assignee: Ark Therapeutics Group, p.l.c.
    Inventors: Hugh Edward Montgomery, John Francis Martin, Jorge Daniel Erusalimsky
  • Publication number: 20110014298
    Abstract: The present invention relates to particle compositions comprising a core particle that is partially coated with a first hydrophilic deposit and a hydrophobic polymeric finish, contains a small amount of water, and a compatible active present in the deposit, the finish or both. Additional alternating deposits, hydrophobic, hydrophilic or both, can be present between the first hydrophilic deposit and the hydrophobic polymeric finish. Similarly, additional compatible actives can be present in one or more of the additional alternating deposits. The invention also relates to methods of preparing the particle compositions.
    Type: Application
    Filed: September 2, 2010
    Publication date: January 20, 2011
    Inventors: FRANCIS MARTIN FRIEL, WILSON AN-TUEN LEE, AYA SHIDARA, CLARA G. MERCADO, ERIC JOHN LEAVER
  • Patent number: 7810313
    Abstract: A method for simultaneously measuring one or more properties (e.g. temperature, concentration of NOx and ammonia, etc) in an exhaust gas mixture. Signals from one or more sensors that are cross-sensitive to one or more gases can be combined. A decoupling observer algorithm can be applied, such that these cross-sensitivities are decoupled. The sensors simultaneously obtain an estimate of one or more gases in the diesel exhaust. A decoupling observer algorithm can be structured and arranged to be operable among a plurality of positions corresponding to several internal configurations.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: October 12, 2010
    Assignee: Honeywell International Inc.
    Inventors: Gregory Edward Stewart, Francis Martin Haran